Newsroom
Sorted by: Latest
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Clean Edge Global Water UCITS ETF 27.07.2026 H2O LN IE000Q8F0M81 600,002.00 USD 12,183,259.22 20.305 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - November 27.07.2026 GNOV LN IE000OJ31JQ4 1,000,002.00 USD 36,922,053.71 36.922 ...
-
HAYA Therapeutics erhält von der FDA den „Fast-Track“-Status für HTX-001
LAUSANNE, Schweiz & SAN DIEGO--(BUSINESS WIRE)--HAYA Therapeutics SA, ein Biotechnologieunternehmen im klinischen Stadium, das Pionierarbeit im Bereich präziser, RNA-gesteuerter Therapeutika leistet, die auf das regulatorische Genom abzielen, um krankheitsauslösende Zellzustände bei häufigen, chronischen und altersbedingten Erkrankungen umzuprogrammieren, gab bekannt, dass die US-amerikanische Arzneimittelbehörde (FDA) für HTX-001 den „Fast-Track“-Status zur Behandlung der symptomatischen nicht...
-
Wescom Financial Earns Great Place To Work® Certification™ for Fourth Consecutive Year
PASADENA, Calif.--(BUSINESS WIRE)--Wescom Financial, a leading member-owned financial institution serving over 250,000 individuals in Southern and Central California, is proud to announce it has been Certified™ by Great Place To Work® for the fourth consecutive year, earning the prestigious workplace recognition in 2023, 2024, 2025 and now 2026. The certification is based entirely on feedback from current employees and recognizes organizations that create an exceptional workplace culture built...
-
HAYA Therapeutics obtient la désignation Fast Track de la FDA pour HTX-001
LAUSANNE, Suisse & SAN DIEGO--(BUSINESS WIRE)--HAYA Therapeutics SA, une société de biotechnologie au stade clinique pionnière dans le domaine des thérapies de précision guidées par l’ARN qui ciblent le génome régulateur afin de reprogrammer les états cellulaires à l’origine de maladies courantes, chroniques et liées à l’âge, a annoncé que la Food and Drug Administration (FDA) américaine avait accordé la désignation Fast Track à HTX-001 pour le traitement de la cardiomyopathie hypertrophique no...
-
HAYA Therapeutics Receives FDA Fast Track Designation for HTX-001
LAUSANNE, Switzerland & SAN DIEGO--(BUSINESS WIRE)--The FDA has granted HAYA Therapeutics Fast Track Designation for HTX-001 for the treatment of symptomatic nonobstructive hypertrophic cardiomyopathy....
-
Turn Therapeutics to Ring the Nasdaq Closing Bell on Monday, August 10, 2026
WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies for inflammatory skin diseases, today announced that Bradley Burnam, Founder and Chief Executive Officer, will ring the Nasdaq Closing Bell on August 10, 2026, along with members of the Turn Therapeutics management team, at Nasdaq's invitation to mark its progress to date. "We're honored that Nasdaq invited us back to share our stor...
-
Ecolab Delivers Accelerated Sales Growth and Double-Digit EPS Growth; Reported Diluted EPS $1.90; Adjusted Diluted EPS $2.09, +11%; Raises 2026 Adjusted Diluted EPS Outlook: $8.05 - $8.25, +7% - 10%
ST. PAUL, Minn.--(BUSINESS WIRE)--Ecolab Inc. (NYSE: ECL): SECOND QUARTER HIGHLIGHTS Ecolab delivered strong performance across the business. Accelerated organic sales growth, driven by good volume growth despite Middle East disruptions and by improved pricing, as well as strong productivity, more than offset rising commodity costs. Reported sales $4.4 billion, +10%. Organic sales growth accelerated to +5%. Growth in Ecolab's core businesses improved, led by accelerating growth in Food & Be...
-
Credit Union 1 (Alaska) Expands Collaboration with NCR Atleos Through Statewide ATM Branding in Circle K Stores
ATLANTA--(BUSINESS WIRE)--NCR Atleos Corporation (NYSE: NATL) (“Atleos”), a leader in expanding self-service financial access for financial institutions, retailers and consumers, today announced that Credit Union 1 (CU1), headquartered in Anchorage, Alaska, is expanding its collaboration with Atleos through an ATM branding agreement at Circle K stores in Alaska, reinforcing its commitment to accessible, convenient self‑service banking for members across the state. Under the agreement, Atleos di...